Is annualised eGFR change associated with reductions in clinical heart failure events with GLP-1 receptor agonists?
Patients in large-scale GLP-1 receptor agonist randomised controlled trials
GLP-1 receptor agonists
Clinical heart failure events and annualised eGFR change
Annualised eGFR change may serve as a useful marker of heart failure benefit with GLP-1 receptor agonists.
Across large-scale GLP-1RA trials, greater annualised eGFR improvement was associated with larger reductions in clinical HF events. Annualised eGFR change may serve as a useful marker of HF benefit with GLP-1RAs.
Building similarity graph...
Analyzing shared references across papers
Loading...
Hasebe et al. (Mon,) studied this question.
www.synapsesocial.com/papers/69df2abce4eeef8a2a6afcd0 — DOI: https://doi.org/10.1111/dom.70749
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
Masashi Hasebe
Hisashi Kamido
Chen‐Yang Su
Diabetes Obesity and Metabolism
McGill University
Kyoto University
McGill University and Génome Québec Innovation Centre
Building similarity graph...
Analyzing shared references across papers
Loading...